Wellington Management Group
RCKT icon

Wellington Management Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Wellington Management Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
+61,605
New +$205K ﹤0.01% 1894
2025
Q2 		– Sell
-12,626,491
Closed -$84.2M – 2031
2025
Q1 		$84.2M Sell
12,626,491
-1,368,686
-10% -$13.5M 0.02% 552
2024
Q4 		$176M Buy
13,995,177
+2,753,033
+24% +$41.4M 0.03% 394
2024
Q3 		$208M Buy
11,242,144
+2,086,424
+23% +$42.7M 0.04% 384
2024
Q2 		$197M Sell
9,155,720
-379
-0% -$8.71K 0.04% 383
2024
Q1 		$247M Buy
9,156,099
+958,553
+12% +$27.2M 0.04% 352
2023
Q4 		$246M Buy
8,197,546
+174,716
+2% +$3.86M 0.05% 356
2023
Q3 		$164M Buy
8,022,830
+2,880,373
+56% +$52.4M 0.03% 416
2023
Q2 		$102M Buy
5,142,457
+1,034,529
+25% +$20.9M 0.02% 539
2023
Q1 		$70.4M Buy
4,107,928
+600,911
+17% +$11.8M 0.01% 617
2022
Q4 		$68.6M Buy
3,507,017
+28,605
+0.8% +$527K 0.01% 609
2022
Q3 		$55.5M Buy
3,478,412
+72,283
+2% +$1.13M 0.01% 645
2022
Q2 		$46.9M Sell
3,406,129
-66,512
-2% -$793K 0.01% 695
2022
Q1 		$55.1M Sell
3,472,641
-18,238
-0.5% -$315K 0.01% 727
2021
Q4 		$76.2M Buy
3,490,879
+144,648
+4% +$3.95M 0.01% 706
2021
Q3 		$100M Sell
3,346,231
-871,744
-21% -$31.7M 0.02% 627
2021
Q2 		$187M Buy
4,217,975
+558,898
+15% +$24.3M 0.03% 458
2021
Q1 		$162M Buy
3,659,077
+977,556
+36% +$53.7M 0.03% 475
2020
Q4 		$147M Buy
2,681,521
+999,916
+59% +$36.5M 0.03% 485
2020
Q3 		$38.4M Sell
1,681,605
-7,385
-0.4% -$182K 0.01% 769
2020
Q2 		$35.4M Buy
1,688,990
+9,510
+0.6% +$171K 0.01% 786
2020
Q1 		$23.4M Sell
1,679,480
-86,165
-5% -$1.71M 0.01% 842
2019
Q4 		$40.2M Buy
1,765,645
+4,574
+0.3% +$76.4K 0.01% 818
2019
Q3 		$20.5M Buy
1,761,071
+1,405,203
+395% +$17.4M ﹤0.01% 954
2019
Q2 		$5.34M Buy
355,868
+82,972
+30% +$1.45M ﹤0.01% 1358
2019
Q1 		$4.79M Buy
+272,896
New +$4.31M ﹤0.01% 1387

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Wellington Management Group's RCKT Position: Q2 2026 in Review

Wellington Management Group opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 61,605 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #1894 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in RCKT as recently as Q1 2025.

Wellington Management Group first reported a position in RCKT in Q1 2019 and has held it in 26 quarters since. The position peaked at $247M in Q1 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Wellington Management Group held 61,605 shares of Rocket Pharmaceuticals worth $211K as of Q2 2026.
  • Rocket Pharmaceuticals was a new Wellington Management Group position in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1894 holding.
  • Wellington Management Group first reported a position in Rocket Pharmaceuticals in Q1 2019 and has held it in 26 quarters since.
  • Wellington Management Group's Rocket Pharmaceuticals position peaked at $247M in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.